How Seasons Affect Kidney Health in Post-Menopausal Females
Seasonal Changes in Kidney Function Among Female Adults Post-Menopause
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Christin Domeier, MS
- Phone Number: 850/644-5807
- Email: cdomeier@fsu.edu
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female aged ≥55 years old
- Self Reported as at least one year post-menopause
- Live in Tallahassee, Florida, or the surrounding area
Exclusion Criteria:
- Have a BMI of ≥30 kg/m2
- Systolic blood pressure of ≥140 and/or diastolic blood pressure ≥90 mmHg
- Self Reported Current or recent (regular use within the past six months) use of a diuretic medication
- Self Reported: Uncontrolled cardiovascular, respiratory, neurological, renal, liver, or metabolic health condition
- Current or recent (regular use within the past six months) use of tobacco, nicotine, nonsteroidal anti-inflammatory products
- No regular (≥once per week) purposeful heat exposure (e.g., sauna, spa, etc.)
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Winter
Assessment of the cohort in winter 2025 (visit 1).
|
This research focuses on examining seasonal variations in kidney function among postmenopausal females.
As an observational study, our approach is non-interventional.
|
|
Summer
Assessment of the cohort in summer 2025 (visit 2).
|
This research focuses on examining seasonal variations in kidney function among postmenopausal females.
As an observational study, our approach is non-interventional.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma neutrophil gelatinase-associated lipocalin (NGAL)
Time Frame: Visit 1 (0 months) and Visit 2 (7 months)
|
Changes in NGAL will be measured in blood samples using enzyme-linked immunosorbent assay.
|
Visit 1 (0 months) and Visit 2 (7 months)
|
|
Urinary neutrophil gelatinase-associated lipocalin (NGAL)
Time Frame: Visit 1 (0 months) and Visit 2 (7 months)
|
Changes in NGAL will be measured in urine samples using radioimmunoassay.
|
Visit 1 (0 months) and Visit 2 (7 months)
|
|
Insulin-like growth factor-binding protein 7 (IGFBP7)*Tissue inhibitor of metalloproteinase-2 (TIMP-2)
Time Frame: Visit 1 (0 months) and Visit 2 (7 months)
|
The product of Insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinase-2 (TIMP-2) will be measured in blood samples using enzyme-linked immunosorbent assays.
|
Visit 1 (0 months) and Visit 2 (7 months)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
estimated glomerular filtration rate (eGFR)
Time Frame: Visit 1 (0 months) and Visit 2 (7 months)
|
eGFR will be calculated from creatinine using CKD-EPI equation.
|
Visit 1 (0 months) and Visit 2 (7 months)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Joseph Watso, PhD, Florida State University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STUDY00005199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.